Molecular modeling study of natural products as potential bioactive compounds against SARS-CoV-2-Reference-Cited by-同舟云学术

Molecular modeling study of natural products as potential bioactive compounds against SARS-CoV-2

Published:2023-05-22 Issue:6 Volume:29 Page:
ISSN:1610-2940
Container-title:Journal of Molecular Modeling
language:en
Short-container-title:J Mol Model

Author:

Ribeiro Rayssa,Botelho Fernanda D.,Pinto Amanda M. V.,La Torre Antonia M. A.,Almeida Joyce S. F. D.,LaPlante Steven R.,Franca Tanos C. C.,Veiga-Junior Valdir F.,dos Santos Marcelo C.

Publisher

Springer Science and Business Media LLC

Subject

Computational Theory and Mathematics,Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Catalysis

Link

https://link.springer.com/content/pdf/10.1007/s00894-023-05586-5.pdf

Reference45 articles.

1. Jo S, Kim S, Shin DH et al (2020) Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzym Inhib Med Ch 35(1):145–151

2. Bambini S, Rappuoli R (2009) The use of genomics in microbial vaccine development. Drug Discov Today 14(5–6):252–260

3. Cao L, Goreshnik I, Coventry B et al (2020) De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science 370(6515):426–431

4. da Silva AA, Wiedemann LSM, Veiga-Junior VF (2020) Natural products’ role against COVID-19. RSC Adv 10(39):23379–23393

5. Sepay N, Sekar A, Halder UC et al (2021) Anti-COVID-19 terpenoid from marine sources: a docking, admet and molecular dynamics study. J Mol Struct 1228:129433

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioprospecting of potential inhibitors of 5alpha reductase 2 inhibitors from relevant ethno-pharmacological plants via in silico techniques;Scientific African;2024-09

2. Potential Anti-Inflammatory and Anti-Fatigue Effects of an Oral Food Supplement in Long COVID Patients;Pharmaceuticals;2024-04-05

3. Exploring host epigenetic enzymes as targeted therapies for visceral leishmaniasis: in silico design and in vitro efficacy of KDM6B and ASH1L inhibitors;Molecular Diversity;2024-03-24